News from rxi pharmaceuticals corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 27, 2016, 07:02 ET RXi Pharmaceuticals to Webcast Third Quarter 2016 Financial Results on Thursday, November 10, 2016

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


Oct 12, 2016, 07:05 ET RXi Pharmaceuticals Plans to Conduct Securities Offering

RXi Pharmaceuticals Corporation (NASDAQ: RXII) announced today that it plans to conduct a securities offering in the near future. RXi plans to use...


Oct 12, 2016, 07:02 ET RXi Pharmaceuticals Enters into Exclusive Option Agreement to Acquire MirImmune Inc.

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


Oct 11, 2016, 07:02 ET RXi Pharmaceuticals to Present at the 15th Annual BIO Investor Forum

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


Sep 19, 2016, 07:02 ET RXi Pharmaceuticals to Present at the 16th Annual Biotech in Europe Forum for Global Partnering and Investment Conference

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


Sep 12, 2016, 07:02 ET RXi Pharmaceuticals to Present at the 4th Targeting Ocular Disorders Conference

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


Sep 07, 2016, 07:02 ET RXi Pharmaceuticals Corporation Selected to Present at Cavendish Global Health Impact Forum

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


Sep 06, 2016, 07:02 ET RXi Pharmaceuticals to Present at the 9th Annual BioPharm America™ Conference

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


Aug 11, 2016, 07:02 ET RXi Pharmaceuticals Reports Second Quarter 2016 Financial Results and Highlights Recent Corporate Developments

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


Jul 28, 2016, 07:02 ET RXi Pharmaceuticals to Webcast Second Quarter 2016 Financial Results on Thursday, August 11, 2016

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


Jul 21, 2016, 07:02 ET RXi Pharmaceuticals to Present at the 2016 Summer Meeting of the American Academy of Dermatology

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


May 12, 2016, 07:02 ET RXi Pharmaceuticals Reports First Quarter 2016 Financial Results and Highlights Recent Corporate Developments

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology...


May 10, 2016, 06:55 ET RXi Pharmaceuticals Provides Strategic Update

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology...


May 04, 2016, 07:02 ET RXi Pharmaceuticals to Present an Update on its Consumer Health Programs at the Society for Investigative Dermatology 75th Annual Meeting

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology...


May 03, 2016, 07:12 ET RXi Pharmaceuticals and Thera Neuropharma Enter into an Exclusive License Agreement for RXi's Self-Delivering RNAi (sd-rxRNA®) Platform Targeting SOD1 to Develop Therapeutics for Neurodegenerative Diseases, such as ALS (Lou Gehrig's Disease)

RXi Pharmaceuticals Corporation (RXi) (NASDAQ: RXII) and privately-held Thera Neuropharma, Inc. (Thera) announced today that they have entered into...


May 02, 2016, 07:02 ET RXi Pharmaceuticals Secures European Patent for Novel RNAi Platform

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology...


Apr 28, 2016, 07:02 ET RXi Pharmaceuticals Announces Advancement of its Ophthalmology Franchise with Successful Topical Delivery of sd-rxRNA to the Cornea in an in vivo Corneal Wound Model

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology...


Apr 27, 2016, 07:02 ET RXi Pharmaceuticals to Webcast First Quarter 2016 Financial Results on Thursday, May 12, 2016

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology...


Apr 26, 2016, 07:02 ET RXi Pharmaceuticals Announces 'Biotech Spotlight' Presentation at the BioNetwork Partnering Summit

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology...


Apr 25, 2016, 07:02 ET RXi Pharmaceuticals to Present at 18th Annual TIDES: Oligonucleotide and Peptides Therapeutics Conference

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology...


Apr 19, 2016, 07:02 ET RXi Pharmaceuticals Fortifies its Novel RNAi Patent Portfolio with Notice of Allowance for Lead Clinical Candidate RXI-109

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology...


Apr 18, 2016, 07:02 ET RXi Pharmaceuticals to Present at the Association for Research in Vision and Ophthalmology 2016 Annual Meeting

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology...


Apr 15, 2016, 02:15 ET RXi Pharmaceuticals Announces Reverse Stock Split

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology...


Mar 31, 2016, 07:02 ET RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Dermal Indications

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology...


Mar 30, 2016, 04:05 ET RXi Pharmaceuticals Reports Fourth Quarter and Year End 2015 Financial Results and Recent Corporate Highlights

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology...